Concordia International Corp Company Profile (NASDAQ:CXRX)

About Concordia International Corp (NASDAQ:CXRX)

Concordia International Corp logoConcordia International Corp, formerly Concordia Healthcare Corp, is a Canada-based pharmaceutical company. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. Its activities are divided into four segments: Concordia North America, includes sales of pharmaceutical products, such as Donnatal for the treatment of irritable bowel syndrome, Zonegran for the treatment of partial seizures in adults with epilepsy and Nilandron for the treatment of metastatic prostate cancer; Concordia International, includes a portfolio of branded and generic products that are sold to wholesalers, hospitals and pharmacies in over 100 countries, and focuses on acquisition, licensing and development of off-patent prescription medicines; Orphan Drugs, includes Photofrin, which is for the treatment of certain forms of rare cancer, and Corporate cost centre, includes centralized costs incurred by the Company.

Industry, Sector and Symbol:
  • Sector:
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CXRX
  • CUSIP: N/A
  • Web: www.concordiarx.com
Capitalization:
  • Market Cap: $65.9 million
  • Outstanding Shares: 51,089,000
Average Prices:
  • 50 Day Moving Avg: $1.39
  • 200 Day Moving Avg: $2.03
  • 52 Week Range: $1.25 - $34.52
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 1.01
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $748.18 million
  • Price / Sales: 0.09
  • Book Value: ($8.59) per share
  • Price / Book: -0.15
Profitability:
  • EBIDTA: $380.7 million
  • Net Margins: -81.40%
  • Return on Equity: 22.81%
  • Return on Assets: 3.48%
Debt:
  • Debt-to-Equity Ratio: 10.65%
  • Current Ratio: 1.02%
  • Quick Ratio: 0.82%
Misc:
  • Average Volume: 521,834 shs.
  • Beta: 0.12
  • Short Ratio: 4.85
 

Frequently Asked Questions for Concordia International Corp (NASDAQ:CXRX)

What is Concordia International Corp's stock symbol?

Concordia International Corp trades on the NASDAQ under the ticker symbol "CXRX."

How were Concordia International Corp's earnings last quarter?

Concordia International Corp (NASDAQ:CXRX) posted its quarterly earnings results on Wednesday, May, 10th. The company reported ($0.37) EPS for the quarter, missing the consensus estimate of $0.52 by $0.89. The firm earned $160.56 million during the quarter, compared to analyst estimates of $168.09 million. Concordia International Corp had a negative net margin of 81.40% and a positive return on equity of 22.81%. The company's revenue was down 29.7% on a year-over-year basis. During the same period last year, the company earned ($0.09) EPS. View Concordia International Corp's Earnings History.

Where is Concordia International Corp's stock going? Where will Concordia International Corp's stock price be in 2017?

8 equities research analysts have issued 12-month target prices for Concordia International Corp's stock. Their predictions range from $0.50 to $14.00. On average, they anticipate Concordia International Corp's share price to reach $9.80 in the next year. View Analyst Ratings for Concordia International Corp.

Who are some of Concordia International Corp's key competitors?

Who are Concordia International Corp's key executives?

Concordia International Corp's management team includes the folowing people:

  • Jordan M. Kupinsky J.D., Chairman of the Board
  • Wayne Kreppner, President, Chief Operating Officer
  • Allan Oberman, Chief Executive Officer, Director
  • David J. Price, Chief Financial Officer
  • Graeme Duncan, President - Company's International Segment
  • Arijit Mookerjee, Managing Director, Chief Financial Officer - Operations
  • Adeel Ahmad, Chief Financial Officer of AMCo
  • Francesco Tallarico, Chief Legal Officer and Secretary
  • Patrick Vink M.D., Director
  • Douglas N. Deeth, Independent Director

Who owns Concordia International Corp stock?

Concordia International Corp's stock is owned by many different of institutional and retail investors. Top institutional investors include Morgan Stanley (1.98%), Renaissance Technologies LLC (0.32%), Continental Advisors LLC (0.28%), Dimensional Fund Advisors LP (0.22%), Toronto Dominion Bank (0.16%) and FMR LLC (0.13%). View Institutional Ownership Trends for Concordia International Corp.

Who sold Concordia International Corp stock? Who is selling Concordia International Corp stock?

Concordia International Corp's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC and Continental Advisors LLC. View Insider Buying and Selling for Concordia International Corp.

Who bought Concordia International Corp stock? Who is buying Concordia International Corp stock?

Concordia International Corp's stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, FMR LLC and Toronto Dominion Bank. View Insider Buying and Selling for Concordia International Corp.

How do I buy Concordia International Corp stock?

Shares of Concordia International Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Concordia International Corp's stock price today?

One share of Concordia International Corp stock can currently be purchased for approximately $1.29.


MarketBeat Community Rating for Concordia International Corp (NASDAQ CXRX)
Community Ranking:  2.8 out of 5 ( )
Outperform Votes:  161 (Vote Outperform)
Underperform Votes:  131 (Vote Underperform)
Total Votes:  292
MarketBeat's community ratings are surveys of what our community members think about Concordia International Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Concordia International Corp (NASDAQ:CXRX) (?)
Ratings Breakdown: 6 Sell Ratings, 2 Hold Ratings
Consensus Rating:Sell (Score: 1.25)
Consensus Price Target: $9.80 (659.69% upside)

Analysts' Ratings History for Concordia International Corp (NASDAQ:CXRX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
3/14/2017Canaccord GenuityReiterated RatingSellHighView Rating Details
2/8/2017TD SecuritiesDowngradeHold -> ReduceN/AView Rating Details
12/9/2016ScotiabankDowngradeSector Perform -> Underperform$2.00 -> $0.50N/AView Rating Details
12/7/2016Royal Bank of CanadaDowngradeSector Perform -> UnderperformN/AView Rating Details
11/7/2016Bloom BurtonDowngradeHold -> SellN/AView Rating Details
9/27/2016Goldman Sachs Group IncReiterated RatingNeutralN/AView Rating Details
8/15/2016CIBCDowngradeSector Perform -> Underperform$7.80N/AView Rating Details
8/15/2016GMP SecuritiesDowngradeBuy -> HoldN/AView Rating Details
3/31/2016LaurentianReiterated RatingBuy$60.00 -> $55.00N/AView Rating Details
3/28/2016Laurentian Bank of CanadaLower Price TargetBuy$60.00 -> $55.00N/AView Rating Details
3/21/2016Dundee SecuritiesLower Price Target$46.50 -> $45.00N/AView Rating Details
12/4/2015MackieReiterated RatingHoldN/AView Rating Details
10/16/2015S&P Equity ResearchReiterated RatingBuy$60.00N/AView Rating Details
7/10/2015Howard WeilInitiated CoverageOutperform$90.00N/AView Rating Details
(Data available from 5/30/2015 forward)

Earnings

Earnings History for Concordia International Corp (NASDAQ:CXRX)
Earnings by Quarter for Concordia International Corp (NASDAQ:CXRX)
Earnings History by Quarter for Concordia International Corp (NASDAQ CXRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/10/20173/31/2017$0.52($0.37)$168.09 million$160.56 millionViewN/AView Earnings Details
3/15/201712/31/2016$0.55$0.13$181.65 million$170.40 millionViewN/AView Earnings Details
11/7/2016Q316$1.03($0.33)$206.00 million$185.50 millionViewListenView Earnings Details
8/12/2016Q216$1.38$1.38$229.76 million$231.70 millionViewN/AView Earnings Details
5/13/2016Q116$1.54$1.35$231.00 million$228.50 millionViewN/AView Earnings Details
3/23/2016Q415$1.32$1.24$166.60 million$191.90 millionViewN/AView Earnings Details
11/12/2015Q315$1.43$1.46$93.11 million$94.90 millionViewN/AView Earnings Details
8/13/2015Q215$1.02$0.96$78.60 million$77.51 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Concordia International Corp (NASDAQ:CXRX)
Current Year EPS Consensus Estimate: $1.26 EPS
Next Year EPS Consensus Estimate: $1.28 EPS

Dividends

Dividend History by Quarter for Concordia International Corp (NASDAQ CXRX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/16/2016quarterly$0.081.03%7/13/20167/15/20167/29/2016
3/24/2016quarterly$0.081.13%4/13/20164/15/20164/29/2016
11/17/2015quarterly$0.080.92%1/13/20161/15/20161/29/2016
8/14/2015quarterly$0.080.39%10/13/201510/15/201510/30/2015
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Concordia International Corp (NASDAQ:CXRX)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Concordia International Corp (NASDAQ:CXRX)
Latest Headlines for Concordia International Corp (NASDAQ:CXRX)
Source:
DateHeadline
americanbankingnews.com logoConcordia International Corp (CXRX) Downgraded by Zacks Investment Research to Strong Sell
www.americanbankingnews.com - May 16 at 6:26 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Given Consensus Recommendation of "Sell" by Analysts
www.americanbankingnews.com - May 15 at 4:40 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Price Target Cut to $0.25 by Analysts at Royal Bank of Canada
www.americanbankingnews.com - May 12 at 4:05 PM
seekingalpha.com logoConcordia International's (CXRX) CEO Allan Oberman Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 4:48 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Posts Quarterly Earnings Results, Misses Expectations By $1.04 EPS
www.americanbankingnews.com - May 10 at 4:34 PM
finance.yahoo.com logoConcordia International Corp. Announces First Quarter 2017 Results
finance.yahoo.com - May 10 at 8:01 AM
finance.yahoo.com logoInvestor Network: Concordia International Corp. to Host Earnings Call
finance.yahoo.com - May 10 at 8:01 AM
finance.yahoo.com logoConcordia International Corp. Announces Two New Appointments to the Board of Directors
finance.yahoo.com - May 4 at 8:01 AM
americanbankingnews.com logo Analysts Anticipate Concordia International Corp (CXRX) Will Post Earnings of $0.52 Per Share
www.americanbankingnews.com - May 4 at 1:06 AM
americanbankingnews.com logoConcordia International Corp (CXRX) Receives Daily Media Sentiment Score of -0.13
www.americanbankingnews.com - May 3 at 9:28 AM
finance.yahoo.com logoRedHill Biopharma Reports 2017 First Quarter Financial Results
finance.yahoo.com - May 3 at 8:00 AM
americanbankingnews.com logo$0.52 Earnings Per Share Expected for Concordia International Corp (CXRX) This Quarter
www.americanbankingnews.com - April 28 at 9:10 AM
americanbankingnews.com logoConcordia International Corp (CXRX) Receiving Somewhat Positive Press Coverage, Analysis Finds
www.americanbankingnews.com - April 27 at 7:28 PM
streetinsider.com logoConcordia International (CXRX) Appoints David Price as CFO
www.streetinsider.com - April 27 at 1:48 AM
americanbankingnews.com logoConcordia International Corp (CXRX) Receives News Impact Score of 0.31
www.americanbankingnews.com - April 21 at 2:33 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Given News Impact Rating of 0.69
www.americanbankingnews.com - April 18 at 9:26 AM
americanbankingnews.com logoConcordia International Corp (CXRX) Receives Daily News Sentiment Score of 0.26
www.americanbankingnews.com - April 15 at 11:21 AM
americanbankingnews.com logoConcordia International Corp (CXRX) Expected to Post Quarterly Sales of $0.00
www.americanbankingnews.com - April 9 at 10:07 AM
americanbankingnews.com logoZacks: Analysts Expect Concordia International Corp (CXRX) to Announce $0.52 Earnings Per Share
www.americanbankingnews.com - April 7 at 8:21 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Sees Significant Growth in Short Interest
www.americanbankingnews.com - April 7 at 8:00 PM
finance.yahoo.com logoETFs with exposure to Concordia International Corp. : April 7, 2017
finance.yahoo.com - April 7 at 4:35 PM
finance.yahoo.com logoCONCORDIA INTERNATIONAL CORP. Financials
finance.yahoo.com - March 24 at 4:52 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - March 24 at 1:01 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - March 24 at 11:59 AM
americanbankingnews.com logoConcordia International Corp (CXRX) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - March 20 at 5:37 PM
seekingalpha.com logoConcordia International's (CXRX) CEO Allan Oberman Q4 2016 Results - Earnings Call Transcript
seekingalpha.com - March 15 at 5:04 PM
americanbankingnews.com logoConcordia International Corp (CXRX) Issues Quarterly Earnings Results
www.americanbankingnews.com - March 15 at 2:57 PM
seekingalpha.com logoConcordia Q4 top line off 8%; net loss $664M; shares slip 8% premarket
seekingalpha.com - March 15 at 9:47 AM
finance.yahoo.com logoConcordia International Corp. Announces Release Date for Fourth Quarter and Year-End 2016 Results
finance.yahoo.com - March 9 at 5:11 PM
us.rd.yahoo.com logoConcordia International Corp. Grant of Treble Damages Further Vindicates Marketing Rights of its Donnatal® Brand
us.rd.yahoo.com - March 6 at 10:17 AM
finance.yahoo.com logoConcordia International Corp. Comments on CMA Statement of Objections Related to Hydrocortisone 10mg
finance.yahoo.com - March 3 at 4:40 PM
finance.yahoo.com logo9:03 am Concordia reponds to CMA statement of objections, believes that the conduct of Amdipharm was not in breach of competition law
finance.yahoo.com - March 3 at 4:40 PM
finance.yahoo.com logoConcordia International Corp. Makes Final Earn Out Payment to Cinven
finance.yahoo.com - February 1 at 5:05 PM
finance.yahoo.com logoRedHill Biopharma Provides 2017 Semi-Annual Business Update
finance.yahoo.com - January 12 at 5:01 PM
streetinsider.com logoConcordia International (CXRX) Enters 3-Year Co-Promotion Deal RedHill Biopharma (RDHL) for Donnatal - StreetInsider.com
www.streetinsider.com - January 3 at 6:23 PM
seekingalpha.com logoConcordia: Executive "Retirement" Another Ominous Sign - Seeking Alpha
seekingalpha.com - December 31 at 3:04 AM
baystreet.ca logoConcordia International (CXRX) Gains on New President
www.baystreet.ca - December 30 at 5:02 PM
seekingalpha.com logoConcordia: Executive "Retirement" Another Ominous Sign
seekingalpha.com - December 29 at 4:59 PM
us.rd.yahoo.com logoConcordia International Corp. Provides Business Update
us.rd.yahoo.com - December 20 at 9:44 AM
us.rd.yahoo.com logo7:04 am Concordia announces they paid the first installment of its earn-out to Cinven relating to the previously announced acquisition of Amdipharm Mercury; payment of GBP 72 mln paid; terminates enrollment in phase 3 trial evaluating PDT w
us.rd.yahoo.com - December 20 at 9:44 AM
seekingalpha.com logoConcordia's Ominous Silence
seekingalpha.com - December 3 at 6:49 AM
seekingalpha.com logoCan Oberman Salvage Concordia?
seekingalpha.com - November 29 at 5:49 PM
seekingalpha.com logoConcordia: A Ship Without A Captain
seekingalpha.com - November 25 at 4:36 PM
benzinga.com logoConcordia Healthcare Bondholder Calls For Immediate Changes, Threatens Lawsuit
www.benzinga.com - November 25 at 4:36 PM
moodys.com logoConcordia International Corp. -- Moody's Downgrades Concordia's CFR to Caa1; outlook negative
www.moodys.com - November 14 at 4:44 PM

Social

Chart

Concordia International Corp (CXRX) Chart for Tuesday, May, 30, 2017

This page was last updated on 5/30/2017 by MarketBeat.com Staff